Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. - Wikidata - wikimedia - TriplyDB

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.

http://www.wikidata.org/entity/Q34056154

about

CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors Human induced pluripotent stem cells for monogenic disease modelling and therapy hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research Induced pluripotent stem cells for modeling neurological disorders Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges Dysregulation and restoration of translational homeostasis in fragile X syndrome Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies Modeling neurodevelopmental disorders using human neurons iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls Channelopathy pathogenesis in autism spectrum disorders Treatment of neurodevelopmental disorders in adulthood Human pluripotent stem cells for modelling human liver diseases and cell therapy Using human induced pluripotent stem cells to treat retinal disease Epigenetic mechanisms in mood disorders: targeting neuroplasticity Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment Biological and medical applications of a brain-on-a-chip Modeling psychiatric disorders at the cellular and network levels iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors.The pur protein family: genetic and structural features in development and disease.Investigating human disease using stem cell models.Increasing our understanding of human cognition through the study of Fragile X Syndrome.Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells Insights into neuroepigenetics through human histone deacetylase PET imaging.Concise review: Fragile X proteins in stem cell maintenance and differentiation Extensive alternative splicing of the repressor element silencing transcription factor linked to cancer.Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cells Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months.Comparison and optimization of hiPSC forebrain cortical differentiation protocols.Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder.

P2860

Q24305288-C3F7A785-EDB6-45E1-8732-5B23BD1952FD Q26750393-52D07D44-6CFE-464B-935B-3BCEACA08847 Q26751506-4793D001-AF36-4CE1-985E-097E138C6BB3 Q26770097-373E4280-A9F8-4B9D-93EE-B6A3C56EF9B8 Q26771402-716558E5-4E58-4BF4-AA6C-BE2EE8A33A5C Q26775061-851F0502-2FA7-4690-AFCC-5BC1FAE0E587 Q26782616-92C9EE61-A0FE-48E7-B327-AF51E943505B Q26784399-2E92B976-F80E-4F9B-BE79-4C3D2666F009 Q26796332-5689405A-7E59-495B-BDBE-BF1C11325C36 Q26825057-3A23C8B2-216D-4704-A82C-B122B0EB311A Q26827249-C3E4C634-685A-48E0-86F4-825ACEF41D04 Q26864726-4B5615D3-19F6-49B8-8C81-97E230645EB3 Q27000307-4AA7F7B8-1C3A-4E12-8B73-A0B48E4D0BA6 Q27005360-9B3162DC-6BDA-4F9C-8117-0445BB26B1FA Q27015087-6E9277F0-CBBD-4658-9065-64047019E167 Q27021810-AD353531-5A0C-4972-9F6C-3D731FDB575D Q27337360-CA1E327B-F41F-4A3D-B427-1F2E894DC815 Q27687330-2C0E46D6-7C0C-4E05-A15E-B6E4A603F2B6 Q28080022-F8B80F4B-C8AE-44AB-9358-26FEC12C15C2 Q28080219-6383F3AE-45D1-4EA1-812B-E171DB9C4C65 Q28081659-36985B4E-441E-4386-8756-07A0A6A52694 Q28973613-39AD1C31-36C7-47FD-AC3E-E2E93B7A18B7 Q30446669-C95F9273-A9DF-4C74-A4B2-A930ABCB2037 Q33919340-30199773-BF22-417F-80D5-8219E42ABD04 Q34393969-96AFE280-2A90-4E1A-BB7E-6E0DB7E43129 Q34423435-27964174-39C6-403F-AB26-E5219161B9ED Q34431170-3DA60FC9-6DA7-4BFD-A1E8-B4AF261518A5 Q34435526-CF3A623A-2538-474B-9820-1A715E06BBEB Q34469474-E0107981-FE0A-4037-A727-55404226A938 Q34530652-81572CE1-1AC3-4AFF-A80B-3B379596E856 Q34536980-66A37020-BF27-4F8A-A71A-D206B11CEAFC Q34632480-EBA39C81-A192-472B-95B3-82A074A8D524 Q34685755-066EDBE8-5BE4-4447-A1D7-841F14A15A20 Q34802401-5B1C1A68-C566-4F51-A698-39FB1842DAFC Q34845881-E4F3429F-2D40-4F1F-A8C3-2AA099080DF8 Q35074117-D6BD1CBA-606E-437F-BF7C-79470E54FF44 Q35213084-1CDBB551-6235-4377-A8FD-57B86A370E13 Q35231766-AAE25664-9C4A-47F3-8BB8-D129F9C48741 Q35233519-B3D1D54E-D0AC-434F-94B6-9AD8DE6902A5 Q35553863-C793AB6D-1BEF-4792-B84C-3F355E65817C

P2860

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.

http://www.wikidata.org/entity/Q34056154

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Epigenetic characterization of ...... models of fragile X syndrome.

@ast

Epigenetic characterization of ...... models of fragile X syndrome.

@en

Epigenetic characterization of ...... models of fragile X syndrome.

@nl

type

label

Epigenetic characterization of ...... models of fragile X syndrome.

@ast

Epigenetic characterization of ...... models of fragile X syndrome.

@en

Epigenetic characterization of ...... models of fragile X syndrome.

@nl

prefLabel

Epigenetic characterization of ...... models of fragile X syndrome.

@ast

Epigenetic characterization of ...... models of fragile X syndrome.

@en

Epigenetic characterization of ...... models of fragile X syndrome.

@nl

P1433

Q34056154-7D2A728A-965D-42CF-92CC-5DB7CAD682E5

P1476

Q34056154-24004B85-8152-4BB5-9852-7E870E30E415

P2093

Q34056154-4A3AE9E0-BAB5-4191-BB30-F31A0427AAE0

Q34056154-560C5D30-015C-409D-A18C-7B57F955CF29

Q34056154-AF94F026-13A9-4025-BD09-99FBE6421113

Q34056154-B982AA2F-7BFB-44AD-9FB1-5443976B6AC8

Q34056154-D4DB6F4B-4B47-4875-91B3-27707E8B2C3D

Q34056154-D56638CE-795F-47C8-8D1F-B4F9DB2C148A

Q34056154-FDCA970F-52C7-4BE6-9CBA-41544E012E32

P2860

Q34056154-04D71119-46B8-4402-9880-6E9A6235C091

Q34056154-05406364-CB99-40CF-8B8C-6C1493E03153

Q34056154-128152A2-E276-4CD8-8B03-A3F22D8DE1A3

Q34056154-167D273A-6CAC-44C1-AD8B-DA7A4589717E

Q34056154-1B2721F6-DB24-49D9-A83B-F4AA29E3C07C

Q34056154-1D5E4DB2-95E8-442D-BEBF-C95DFF5C2F2C

Q34056154-1D8E3F32-093C-48BF-8B73-5C89A4FC27C1

Q34056154-21280643-F3BA-4C12-85EC-38A4181AC75D

Q34056154-23CDFAB2-2317-43AF-9715-838C092BDAEA

Q34056154-24148F45-C469-40B9-8A33-626D06B38CEC

P304

Q34056154-612512FC-BB50-41F7-AA76-CD22884E7618

P31

Q34056154-8E420017-CEF6-47CC-8C7D-CCADC890178D

P356

Q34056154-8C0E8515-3EFA-4710-A624-B1F0DE9B68D1

P407

Q34056154-CA6F2085-49D8-494B-BD5A-A81527ED565B

P433

Q34056154-48FBBF0F-2D34-40F7-8152-80ED8FC1AA87

P478

Q34056154-94EAC570-55B7-4529-917B-A8081BD9A27C

P50

Q34056154-F860E8EA-EAF9-4B8B-BFBA-AC3E65F916D1

P577

Q34056154-D07B4217-8C00-4082-8924-F8EDAB6E4AF9

P5875

Q34056154-4F2D0A44-93CF-4821-8727-4DB6FF46022B

P698

Q34056154-47CC5B65-DBB7-4D2B-982C-1E5164024D20

P921

Q34056154-58E1A312-AF13-44CC-ADF1-784197797648

P932

Q34056154-81C735D8-9970-4E46-A486-7175A51D83B3

P356

JOURNAL.PONE.0026203

P1433

P1476

Epigenetic characterization of ...... models of fragile X syndrome.

@en

P2093

Fen Zhou

http://www.w3.org/2001/XMLSchema#string

Jeanne F Loring

http://www.w3.org/2001/XMLSchema#string

Jon M Madison

http://www.w3.org/2001/XMLSchema#string

Kraig M Theriault

http://www.w3.org/2001/XMLSchema#string

Laurence Daheron

http://www.w3.org/2001/XMLSchema#string

Steven D Sheridan

http://www.w3.org/2001/XMLSchema#string

Surya A Reis

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in autism

A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE.

FMR1 protein: conserved RNP family domains and selective RNA binding

Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of

Advances in the treatment of fragile X syndrome

The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein

Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing

Reprogramming of human somatic cells to pluripotency with defined factors

P304

e26203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0026203

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Haggarty

P577

2011-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51737899

http://www.w3.org/2001/XMLSchema#string

P698

22022567

http://www.w3.org/2001/XMLSchema#string

P921

Human Induced Pluripotent Stem Cells

P932

3192166

http://www.w3.org/2001/XMLSchema#string